Nutriband Inc
NTRB4.490USD
-0.040-0.88%
收盘 12/19, 16:00（美东）报价延迟15分钟
54.58M总市值
亏损市盈率 TTM
关于 Nutriband Inc 公司
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Nutriband Inc简介
公司代码NTRB
公司名称Nutriband Inc
上市日期Jun 20, 2017
CEOMelnik (Serguei)
员工数量- -
证券类型Ordinary Share
年结日Jun 20
公司地址121 S Orange Ave Ste 1500
城市ORLANDO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编32801-3241
电话14073776695
网址https://nutriband.com/
公司代码NTRB
上市日期Jun 20, 2017
CEOMelnik (Serguei)
Nutriband Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
820.42K
--
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
17.21K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Mr. Sergei Glinka
Mr. Sergei Glinka
Independent Director
Independent Director
--
--
Prof. Dr. Stefani C. Mancas
Prof. Dr. Stefani C. Mancas
Independent Director
Independent Director
--
--
Dr. Alan Smith, Ph.D.
Dr. Alan Smith, Ph.D.
Chief Operating Officer, President of 4P Therapeutics
Chief Operating Officer, President of 4P Therapeutics
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
820.42K
--
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
17.21K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Sale of goods
622.45K
0.00%
Services
0.00
0.00%
地区USD
名称
营收
占比
United States
614.92K
98.79%
Non-United States
7.53K
1.21%
业务
地区
业务USD
名称
营收
占比
Sale of goods
622.45K
0.00%
Services
0.00
0.00%
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Botgros (Vitalie)
26.44%
TII Jet Services, LDA
14.85%
Sheridan (Gareth)
14.47%
Glinka (Serguei)
9.19%
Melnik (Serguei)
7.72%
其他
27.33%
持股股东
持股股东
占比
Botgros (Vitalie)
26.44%
TII Jet Services, LDA
14.85%
Sheridan (Gareth)
14.47%
Glinka (Serguei)
9.19%
Melnik (Serguei)
7.72%
其他
27.33%
股东类型
持股股东
占比
Individual Investor
59.53%
Corporation
14.85%
Investment Advisor
2.21%
Investment Advisor/Hedge Fund
0.82%
Research Firm
0.04%
其他
22.55%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
36
350.65K
2.91%
-71.29K
2025Q2
44
8.87M
79.52%
+489.89K
2025Q1
43
8.13M
73.14%
+1.78M
2024Q4
40
8.04M
72.39%
+1.68M
2024Q3
40
8.08M
72.79%
+1.82M
2024Q2
38
5.19M
52.25%
+2.18M
2024Q1
34
4.36M
55.65%
+1.38M
2023Q4
30
4.30M
54.90%
+1.31M
2023Q3
29
2.96M
37.78%
-39.44K
2023Q2
28
2.95M
37.71%
-29.57K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Botgros (Vitalie)
3.09M
25.65%
--
--
Jun 20, 2025
TII Jet Services, LDA
1.81M
15.02%
+485.05K
+36.66%
Sep 01, 2024
Sheridan (Gareth)
1.76M
14.64%
--
--
Jun 20, 2025
Glinka (Serguei)
825.00K
6.86%
--
--
Jun 20, 2025
Melnik (Serguei)
820.42K
6.82%
--
--
Jun 20, 2025
The Vanguard Group, Inc.
199.63K
1.66%
+600.00
+0.30%
Jun 30, 2025
Goodman (Gerald)
86.33K
0.72%
--
--
Jun 20, 2025
Geode Capital Management, L.L.C.
63.63K
0.53%
+81.00
+0.13%
Jun 30, 2025
Smith (Allan)
41.91K
0.35%
--
--
Jun 20, 2025
Patrick (Jeff)
36.61K
0.3%
--
--
Jun 20, 2025
查看更多
持股ETF
更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jul 29, 2022
Split
6→7
公告日期
类型
比率
Jul 29, 2022
Split
6→7
常见问题
Nutriband Inc的前五大股东是谁？
Nutriband Inc 的前五大股东如下：
Botgros (Vitalie)持有股份：3.09M，占总股份比例：25.65%。
TII Jet Services, LDA持有股份：1.81M，占总股份比例：15.02%。
Sheridan (Gareth)持有股份：1.76M，占总股份比例：14.64%。
Glinka (Serguei)持有股份：825.00K，占总股份比例：6.86%。
Melnik (Serguei)持有股份：820.42K，占总股份比例：6.82%。
Botgros (Vitalie)持有股份：3.09M，占总股份比例：25.65%。
TII Jet Services, LDA持有股份：1.81M，占总股份比例：15.02%。
Sheridan (Gareth)持有股份：1.76M，占总股份比例：14.64%。
Glinka (Serguei)持有股份：825.00K，占总股份比例：6.86%。
Melnik (Serguei)持有股份：820.42K，占总股份比例：6.82%。
Nutriband Inc的前三大股东类型是什么？
Nutriband Inc 的前三大股东类型分别是：
Botgros (Vitalie)
TII Jet Services, LDA
Sheridan (Gareth)
Botgros (Vitalie)
TII Jet Services, LDA
Sheridan (Gareth)
有多少机构持有Nutriband Inc(NTRB)的股份？
截至2025Q3，共有36家机构持有Nutriband Inc的股份，合计持有的股份价值约为350.65K，占公司总股份的2.91%。与2025Q2相比，机构持股有所增加，增幅为-76.60%。
哪个业务部门对Nutriband Inc的收入贡献最大？
在FY2026Q2，Sale of goods业务部门对Nutriband Inc的收入贡献最大，创收622.45K，占总收入的--%。
